Delivery Order SPE2DB22D3019-SPE2DB25FK4HW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $13,924.72. The award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $36,477.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Jardiance 10mg tablets in a 90-count configuration, with a ceiling value of $37,525.90. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-set-aside competitive award to the prime contractor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $17,911.04 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,586.88. The contract, awarded on September 24, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $9,728.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is due for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract value of $20,313.12. This firm fixed-price delivery order, with completion targeted for September 23, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4HWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract. The award, issued on September 26, 2025, carries a ceiling value of $26,376.14 with an ultimate completion date of September 29, 2025. This non-set-aside delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion vehicle that extends through December 2026 and enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Jardiance delivery exemplifies the company's role as a critical pharmaceutical vendor for federal medical procurement, providing diabetes medications and other therapeutic products to defense and veteran healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.4k | 9/26/25 |